Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fluorouracil

Known as: 5-Fluracil, 5-Fluoro-2,4(1H,3H)-pyrimidinedione, Fluouracil 
An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. Fluorouracil and its metabolites possess a… Expand
National Institutes of Health

Related topics

Related topics

49 relations
10 ML Fluorouracil 50 MG/ML InjectionCAFVP protocolCFP protocolCMF-B protocol
Expand

Narrower (20)

COFP protocol 1CytosafeFCC protocolFDV protocol
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial.
Importance Patients with locally advanced pancreatic cancer have historically poor outcomes. Evaluation of a total neoadjuvant… Expand
Review
2019
Review
2019
Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
Tumor formation and growth depend on various biological metabolism processes that are distinctly different with normal tissues… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2018
Review
2018
The Influence of Metabolism on Drug Response in Cancer
Resistance to therapeutic agents, either intrinsic or acquired, is currently a major problem in the treatment of cancers and… Expand
  • figure 1
  • table 1
  • figure 2
Review
2018
Review
2018
The role of TGF-β/SMAD4 signaling in cancer
Transforming growth factor β (TGF-β) signaling pathway plays important roles in many biological processes, including cell growth… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Review
2018
Review
2018
Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.
Purpose In 2016, ASCO published a guideline to assist in clinical decision making in metastatic pancreatic cancer for initial… Expand
  • table 1
  • table 2
Review
2018
Review
2018
Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature
Colorectal cancer is the third most common cancer worldwide with a high mortality rate at the advanced stages. However… Expand
  • table 1
  • table 2
Review
2018
Review
2018
5-fluorouracil and cardiotoxicity: a review
Fluoropyrimidines such as 5-fluorouracil (5-FU) form the foundation of a wide variety of chemotherapy regimens. 5-FU is in fact… Expand
  • table 1
  • table 1
  • figure 1
  • figure 2
  • table 2
Review
2018
Review
2018
Therapeutic developments in pancreatic cancer: current and future perspectives
The overall 5-year survival for pancreatic cancer has changed little over the past few decades, and pancreatic cancer is… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Review
2017
Review
2017
Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review.
The objective of this systematic review was to provide current evidence regarding the use of adjuvant systemic chemotherapy for… Expand
Review
2017
Review
2017
Pancreatic Cancer Chemoresistance to Gemcitabine
Pancreatic ductal adenocarcinoma (PDAC), commonly referred to as pancreatic cancer, ranks among the leading causes of cancer… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE